Concentric Capital Strategies’s Oracle ORCL Stock Holding History

Concentric Capital Strategies’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-46,700	Closed	-$6.59M	–	353
2024 Q2	$6.59M	Buy	+46,700	New	+$5.8M	0.33%	66

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Concentric Capital Strategies's ORCL Position: Q2 2026 in Review

Concentric Capital Strategies sold out of Oracle (ORCL) in Q2 2026, closing a stake of 4,730 shares — an estimated $696K sold.

Concentric Capital Strategies first reported a position in ORCL in Q3 2022 and held it in 12 quarters. The position peaked at $19.8M in Q2 2025. 3,529 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Concentric Capital Strategies reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
Concentric Capital Strategies sold 4,730 Oracle shares in Q2 2026, an estimated $696K.
Concentric Capital Strategies first reported a position in Oracle in Q3 2022 and held it in 12 quarters.
Concentric Capital Strategies's Oracle position peaked at $19.8M in Q2 2025.
3,529 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.